Filana Therapeutics, Inc. (FLNA) Tops Q1 EPS by 10c

Filana Therapeutics, Inc. (NASDAQ: FLNA) reported Q1 EPS of ($0.21), $0.10 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Filana Therapeutics, Inc. (FLNA) click here.

You May Also Be Interested In

• MetLife estimates Q2 2026 variable investment income below annual pace
• Honeywell completes aerospace spin-off, splits into 3 companies
• BMO Capital Upgrades Casey's General Stores (CASY) to Outperform, 'Opportunity Knocks'